Fonar Pre-Tax Profit Margin 2010-2025 | FONR
Fonar pre-tax profit margin from 2010 to 2025. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Fonar Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2025-03-31 | $0.10B | $0.01B | 13.59% |
| 2024-12-31 | $0.10B | $0.01B | 13.73% |
| 2024-09-30 | $0.10B | $0.02B | 16.67% |
| 2024-06-30 | $0.10B | $0.02B | 18.45% |
| 2024-03-31 | $0.10B | $0.02B | 19.42% |
| 2023-12-31 | $0.10B | $0.02B | 20.59% |
| 2023-09-30 | $0.10B | $0.02B | 18.81% |
| 2023-06-30 | $0.10B | $0.02B | 16.33% |
| 2023-03-31 | $0.10B | $0.02B | 17.53% |
| 2022-12-31 | $0.10B | $0.02B | 18.56% |
| 2022-09-30 | $0.10B | $0.02B | 21.65% |
| 2022-06-30 | $0.10B | $0.02B | 24.49% |
| 2022-03-31 | $0.10B | $0.02B | 24.49% |
| 2021-12-31 | $0.10B | $0.02B | 22.92% |
| 2021-09-30 | $0.09B | $0.02B | 21.51% |
| 2021-06-30 | $0.09B | $0.02B | 18.89% |
| 2021-03-31 | $0.09B | $0.01B | 16.28% |
| 2020-12-31 | $0.09B | $0.01B | 15.29% |
| 2020-09-30 | $0.09B | $0.01B | 15.29% |
| 2020-06-30 | $0.09B | $0.02B | 17.44% |
| 2020-03-31 | $0.09B | $0.02B | 20.69% |
| 2019-12-31 | $0.09B | $0.02B | 25.00% |
| 2019-09-30 | $0.09B | $0.02B | 26.14% |
| 2019-06-30 | $0.09B | $0.02B | 26.44% |
| 2019-03-31 | $0.09B | $0.02B | 27.91% |
| 2018-12-31 | $0.08B | $0.02B | 25.00% |
| 2018-09-30 | $0.08B | $0.02B | 25.30% |
| 2018-06-30 | $0.08B | $0.02B | 24.69% |
| 2018-03-31 | $0.08B | $0.02B | 23.46% |
| 2017-12-31 | $0.08B | $0.02B | 26.25% |
| 2017-09-30 | $0.08B | $0.02B | 25.64% |
| 2017-06-30 | $0.08B | $0.02B | 25.64% |
| 2017-03-31 | $0.08B | $0.02B | 25.00% |
| 2016-12-31 | $0.08B | $0.02B | 22.67% |
| 2016-09-30 | $0.08B | $0.02B | 21.33% |
| 2016-06-30 | $0.07B | $0.02B | 20.27% |
| 2016-03-31 | $0.07B | $0.02B | 20.83% |
| 2015-12-31 | $0.07B | $0.01B | 20.00% |
| 2015-09-30 | $0.07B | $0.01B | 18.84% |
| 2015-06-30 | $0.07B | $0.01B | 17.39% |
| 2015-03-31 | $0.07B | $0.01B | 15.94% |
| 2014-12-31 | $0.07B | $0.01B | 14.49% |
| 2014-09-30 | $0.07B | $0.01B | 14.29% |
| 2014-06-30 | $0.07B | $0.01B | 15.94% |
| 2014-03-31 | $0.07B | $0.01B | 17.14% |
| 2013-12-31 | $0.07B | $0.01B | 18.46% |
| 2013-09-30 | $0.06B | $0.01B | 19.30% |
| 2013-06-30 | $0.05B | $0.01B | 18.00% |
| 2013-03-31 | $0.04B | $0.01B | 18.60% |
| 2012-12-31 | $0.04B | $0.01B | 19.51% |
| 2012-09-30 | $0.04B | $0.01B | 20.00% |
| 2012-06-30 | $0.04B | $0.01B | 20.00% |
| 2012-03-31 | $0.04B | $0.01B | 16.22% |
| 2011-12-31 | $0.04B | $0.01B | 13.89% |
| 2011-09-30 | $0.04B | $0.00B | 11.43% |
| 2011-06-30 | $0.03B | $0.00B | 5.88% |
| 2011-03-31 | $0.04B | $0.00B | 5.71% |
| 2010-12-31 | $0.03B | $0.00B | 2.94% |
| 2010-09-30 | $0.03B | $0.00B | -2.94% |
| 2010-06-30 | $0.03B | $0.00B | -9.38% |
| 2010-03-31 | $0.03B | $0.00B | -9.09% |
| 2009-12-31 | $0.04B | $0.00B | -5.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.096B | $0.103B |
| FONAR Corporation is a developer and manufacturer of MRI scanners. The Company has introduced the world's first commercial MRI in 1980, and went public in 1981. FONAR's stellar product is the UPRIGHT MRI, also known as the Stand-Up MRI, the whole-body MRI that performs Position imaging and scans patients in numerous weight-bearing positions like standing, sitting, in flexion and extension, as well as the conventional lie-down position. The Company's subsidiary, Health Management Corporation of America, is a physician practice management company providing management services to medical providers. FONAR Corporation is based in Melville, New York. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $232.616B | 27.97 |
| Boston Scientific (BSX) | United States | $153.611B | 38.46 |
| Stryker (SYK) | United States | $149.817B | 31.33 |
| EssilorLuxottica (ESLOY) | France | $128.259B | 0.00 |
| Medtronic (MDT) | Ireland | $112.441B | 15.94 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.320B | 0.00 |
| Haleon (HLN) | United Kingdom | $45.596B | 26.03 |
| ResMed (RMD) | United States | $37.597B | 28.24 |
| GE HealthCare Technologies (GEHC) | United States | $34.163B | 16.22 |
| Agilent Technologies (A) | United States | $33.875B | 22.08 |
| Terumo (TRUMY) | Japan | $24.770B | 32.17 |
| Koninklijke Philips (PHG) | Netherlands | $22.956B | 16.11 |
| Insulet (PODD) | United States | $21.162B | 83.07 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.315B | 11.76 |
| Baxter (BAX) | United States | $15.236B | 11.38 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.113B | 0.00 |
| Demant (WILYY) | Denmark | $8.971B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.479B | 13.82 |
| Prestige Consumer Healthcare (PBH) | United States | $3.900B | 17.42 |
| Perrigo (PRGO) | Ireland | $3.676B | 9.32 |
| Haemonetics (HAE) | United States | $3.609B | 16.44 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.334B | 27.70 |
| ICU Medical (ICUI) | United States | $3.192B | 23.54 |
| QuidelOrtho (QDEL) | United States | $1.976B | 13.59 |
| LeMaitre Vascular (LMAT) | United States | $1.875B | 41.91 |
| AtriCure (ATRC) | United States | $1.561B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Phibro Animal Health (PAHC) | United States | $1.212B | 15.49 |
| Green Thumb Industries (GTBIF) | United States | $1.163B | 26.16 |
| Neogen (NEOG) | United States | $1.081B | 13.83 |
| BioLife Solutions (BLFS) | United States | $1.036B | 0.00 |
| InMode (INMD) | Israel | $0.954B | 9.62 |
| Kestra Medical Technologies (KMTS) | United States | $0.757B | 0.00 |
| Owens & Minor (OMI) | United States | $0.669B | 5.55 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.662B | 0.00 |
| CeriBell (CBLL) | United States | $0.622B | 0.00 |
| Evolus (EOLS) | United States | $0.589B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.507B | 0.00 |
| Valneva SE (VALN) | France | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.452B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.360B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.344B | 12.67 |
| SNDL (SNDL) | Canada | $0.326B | 0.00 |
| Quanterix (QTRX) | United States | $0.315B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.284B | 0.00 |
| Cerus (CERS) | United States | $0.277B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.272B | 22.90 |
| ZimVie (ZIMV) | United States | $0.263B | 11.94 |
| Sanara MedTech (SMTI) | United States | $0.259B | 0.00 |
| Brainsway (BWAY) | Israel | $0.253B | 66.85 |
| Aurora Cannabis (ACB) | Canada | $0.249B | 73.83 |
| Cresco Labs (CRLBF) | United States | $0.247B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.228B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.221B | 0.00 |
| Biote (BTMD) | United States | $0.218B | 6.14 |
| TriSalus Life Sciences (TLSI) | United States | $0.188B | 0.00 |
| High Tide (HITI) | Canada | $0.188B | 0.00 |
| Organigram Global (OGI) | Canada | $0.186B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.186B | 15.13 |
| Omeros (OMER) | United States | $0.180B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.173B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 15.90 |
| Apyx Medical (APYX) | United States | $0.098B | 0.00 |
| Jin Medical (ZJYL) | China | $0.090B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.076B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.075B | 0.00 |
| Agape ATP (ATPC) | $0.070B | 0.00 | |
| InterCure (INCR) | Israel | $0.068B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.064B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.062B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.29 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| Safety Shot (SHOT) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.038B | 13.10 |
| Rockwell Medical (RMTI) | United States | $0.027B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.015B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Senestech (SNES) | United States | $0.012B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |